Browse by Current Cardiff authors

Millington, Adam, Batchelor, Jonathan M, Thomas, Kim S, Akram, Perways, Azad, Jaskiran, Bewley, Anthony, Chalmers, Joanne R, Cheung, Seau Tak, Duley, Lelia, Eleftheriadou, Viktoria, Ellis, Robert, Ferguson, Adam, Goulding, Jonathan MR, Haines, Rachel H, Hamad, Hamdi, Ingram, John R, Laguda, Bisola, Leighton, Paul, Levell, Nick, Makrygeorgou, Areti, Meakin, Garry D, Ogboli, Malobi, Rajasekaran, Amirtha, Ravenscroft, Jane C, Rogers, Andrew, Sach, Tracey H, Santer, Miriam, Stainforth, Julia, Tan, Wei, Wahie, Shyamal, White, Jennifer, Whitton, Maxine E, Williams, Hywel C, Wright, Andrew and Montgomery, Alan A 2020. Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT. Health Technology Assessment 24 (64) , pp. 1-183. 10.3310/hta24640

Ingram, J. R., Collins, H., Atkinson, M. D. and Brooks, C. J. 2020. The prevalence of hidradenitis suppurativa is shown by the Secure Anonymised Information Linkage (SAIL) Databank to be one per cent of the population of Wales. British Journal of Dermatology 183 (5) , pp. 950-952. 10.1111/bjd.19210

Naik, H. B., Alhusayen, R., Frew, J., Guilbault, S., Ingram, J. R., Lowes, M. A., Marzano, A. V., Paul, M., Villumsen, B. and Yannuzzi, C. A. 2020. Global hidradenitis suppurativa COVID-19 registry: a registry to inform data-driven management practices. British Journal of Dermatology 183 (4) , pp. 780-781. 10.1111/bjd.19345 Item availability restricted.

Altayeb, Alla, Cordaro, Andrea, Caesar, Jenny, Vyas, Jui and Ingram, John 2020. Two cases of skin manifestations prior to the onset of COVID-19 respiratory symptoms. International Journal of Dermatology 10.1111/ijd.15247

Zouboulis, Christos C., Benhadou, Farida, Byrd, Angel S., Chandran, Nisha S., Giamarellos?Bourboulis, Evangelos J., Fabbrocini, Gabriella, Frew, John W., Fujita, Hideki, González?López, Marcos A., Guillem, Philippe, Gulliver, Wayne P.F., Hamzavi, Iltefat, Hayran, Yildiz, Hórvath, Barbara, Hüe, Sophie, Hunger, Robert E., Ingram, John R., Jemec, Gregor B.E., Ju, Qiang, Kimball, Alexa B., Kirby, Joslyn S., Konstantinou, Maria P., Lowes, Michelle A., MacLeod, Amanda S., Martorell, Antonio, Marzano, Angelo V., Matusiak, ?ukasz, Nassif, Aude, Nikiphorou, Elena, Nikolakis, Georgios, Nogueira da Costa, André, Okun, Martin M., Orenstein, Lauren A.V., Pascual, José Carlos, Paus, Ralf, Perin, Benjamin, Prens, Errol P., Röhn, Till A., Szegedi, Andrea, Szepietowski, Jacek C., Tzellos, Thrasyvoulos, Wang, Baoxi and van der Zee, Hessel H. 2020. What causes hidradenitis suppurativa ? - 15 years after. Experimental Dermatology 10.1111/exd.14214 Item availability restricted.

Thomas, K.S., Batchelor, J.M., Akram, P., Chalmers, J.R., Haines, RH, Meakin, G.D., Duley, L., Ravenscroft, J.C., Rogers, A., Sach, T.H., Santer, M., Tan, W., White, J., Whitton, M.E., Williams, H.C., Cheung, S.T., Hamad, H., Wright, A., Ingram, J.R., Levell, N.J., Goulding, J.M.R., Makrygeorgou, A., Bewley, A., Ogboli, M., Stainforth, J., Ferguson, A., Laguda, B., Wahie, S., Ellis, R., Azad, J., Rajasekaran, A., Eleftheriadou, V. and Montgomery, A.A. 2020. Randomised controlled trial of topical corticosteroid and home-based narrowband UVB for active and limited vitiligo - results of the HI-Light Vitiligo trial. British Journal of Dermatology 10.1111/bjd.19592 Item availability restricted.

Sach, T.H., Thomas, K.S., Batchelor, J.M., Akram, P., Chalmers, J.R., Haines, R.H., Meakin, G.D., Duley, L., Ravenscroft, J.C., Rogers, A., Santer, M., Tan, W., White, J., Whitton, M.E., Williams, H.C., Cheung, S.T., Hamad, H., Wright, A., Ingram, J.R., Levell, N., Goulding, J.M.R., Makrygeorgou, A., Bewley, A., Ogboli, M., Stainforth, J., Ferguson, A., Laguda, B., Wahie, S., Ellis, R., Azad, J., Rajasekaran, A., Eleftheriadou, V. and Montgomery, A.A. 2020. An economic evaluation of the randomised controlled trial of topical corticosteroid and home‐based narrowband UVB for active and limited vitiligo (The HI‐Light Trial). British Journal of Dermatology 10.1111/bjd.19554

Ingram, John R. 2020. The epidemiology of hidradenitis suppurativa. British Journal of Dermatology 10.1111/bjd.19435

Vergnano, Marta, Mockenhaupt, Maja, Benzian-Olsson, Natashia, Paulmann, Maren, Grys, Katarzyna, Mahil, Satveer K., Chaloner, Charlotte, Barbosa, Ines A., August, Suzannah, Burden, A. David, Choon, Siew-Eng, Cooper, Hywel, Navarini, Alex A., Reynolds, Nick J., Wahie, Shyamal, Warren, Richard B., Wright, Andrew, Huffmeier, Ulrike, Baum, Patrick, Visvanathan, Sudha, Barker, Jonathan N., Smith, Catherine H., Capon, Francesca, Abraham, Thamir, Ali, Mahmud, August, Suzannah, Baudry, David, Bewley, Anthony, Cooper, Hywel, Ingram, John, Kelly, Susan, Korshid, Mohsen, Ladoyanni, Effie, McKenna, John, Meynell, Freya, Parslew, Richard, Patel, Prakash, Pushparajah, Angela, Reynolds, Nick, Smith, Catherine, Wahie, Shyamal, Warren, Richard and Wright, Andrew 2020. Loss-of-function myeloperoxidase mutations are associated with increased neutrophil counts and pustular skin disease. American Journal of Human Genetics 107 (3) , pp. 539-543. 10.1016/j.ajhg.2020.06.020

Ahmed, S., Shipman, A., Millington, G., Langan, E. A. and Ingram, J. R. 2020. Consent for publication: why it matters now more than ever. British Journal of Dermatology 183 (3) , pp. 409-410. 10.1111/bjd.19320 Item availability restricted.

Kirby, J.S., Thorlacius, L., Villumsen, B., Ingram, J.R., Garg, A., Christensen, K.B., Butt, M., Esmann, S., Tan, J. and Jemec, G.B.E. 2020. The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials. British Journal of Dermatology 183 (2) , pp. 340-348. 10.1111/bjd.18692

Zouboulis, Christos C., Gulliver, Wayne, Ingram, John, Kirby, Brian, Giamarellos-Bourboulis, Evangelos J., Podda, Maurizio, Tzellos, Thrasyvoulos and Jemec, Gregor B. E. 2020. Endpoints of clinical trials for Hidradenitis Suppurativa: proceedings of a round-table session. Experimental Dermatology 29 (S1) , pp. 67-72. 10.1111/exd.14123

Soriano, L. F., Poole, H., Ingram, J. R. and Abbott, R. A. 2020. Effectiveness of a stop smoking service in reducing cigarette smoking in patients referred from an NHS dermatology centre. British Journal of Dermatology 10.1111/bjd.19378 Item availability restricted.

Zuuren, E. J., Arents, B. W. M., Flohr, C. and Ingram, J. R. 2020. Publication of national dermatology guidelines as a research letter in the BJD : can less ever be enough? British Journal of Dermatology 182 (6) , pp. 1319-1320. 10.1111/bjd.18952 Item availability restricted.

Kirby, J .S., Hereford, B., Thorlacius, L., Villumsen, B., Ingram, J. R., Garg, A., Butt, M., Esmann, S., King, T., Tan, J. and Jemec, G. B. E. 2020. Validation of patient global item for quality of life impact on Hidradenitis suppurativa. British Journal of Dermatology 10.1111/bjd.19344 Item availability restricted.

Hasan, S.B. and Ingram, J.R. 2020. What has changed in the UK management of hidradenitis suppurativa from 2014 to 2019? British Journal of Dermatology 10.1111/bjd.19302 Item availability restricted.

Freeman, Esther E., McMahon, Devon E., Hruza, George J., Irvine, Alan D., Spuls, Phyllis I., Smith, Catherine H., Mahil, Satveer K., Castelo-Soccio, Leslie, Cordoro, Kelly M., Lara-Corrales, Irene, Naik, Haley B., Alhusayen, Raed, Ingram, John R., Feldman, Steven R., Balogh, Esther A., Kappelman, Michael D., Wall, Dmitri, Meah, Nekma, Sinclair, Rodney, Beylot-Barry, Marie, Fitzgerald, Matthew, French, Lars E., Lim, Henry W., Griffiths, Christopher E. M. and Flohr, Carsten 2020. International collaboration and rapid harmonization across dermatologic COVID-19 registries. Journal of The American Academy of Dermatology 10.1016/j.jaad.2020.06.050 Item availability restricted.

Hasan, S.B., Ali, F.M. and Ingram, J.R. 2020. Cholinergic pruritus responding to Omalizumab. Clinical and Experimental Dermatology 45 (2) , pp. 264-266. 10.1111/ced.14052

Jung, F., Sibbald, C., Bohdanowicz, M., Ingram, J. R. and Piguet, V. 2020. Systematic review of efficacies and adverse effects of treatments for Pityriasis lichenoides. British Journal of Dermatology 10.1111/bjd.18977 Item availability restricted.

Garg, Amit, Neuren, Erica, Cha, Denny, Kirby, Joslyn S., Ingram, John R., Jemec, Gregor B.E., Esmann, Solveig, Thorlacius, Linnea, Villumsen, Bente, Marmol, Véronique del, Nassif, Aude, Delage, Maia, Tzellos, Thrasyvoulos, Moseng, Dagfinn, Grimstad, Øystein, Naik, Haley, Micheletti, Robert, Guilbault, Sandra, Miller, Angie Parks, Hamzavi, Iltefat, van der Zee, Hessel, Prens, Errol, Kappe, Naomi, Ardon, Christine, Kirby, Brian, Hughes, Rosalind, Zouboulis, Christos, Nikolakis, Georgios, Bechara, Falk G., Matusiak, Lukasz, Szepietowski, Jacek, Glowaczewska, Amelia, Smith, Saxon D., Goldfarb, Noah, Daveluy, Steven, Avgoustou, Christina, Giamarellos-Bourboulis, Evangelos, Cohen, Steven, Soliman, Yssra, Brant, Elena Gonzalez, Akilov, Oleg, Sayed, Christopher, Tan, Jerry, Alavi, Afsaneh, Lowes, Michelle A., Pascual, José Carlos, Riad, Hassan, Fisher, Shani, Cohen, Arnon, Paek, So Yeon, Resnik, Barry, Ju, Qiang, Wang, Lanqi and Strunk, Andrew 2020. Evaluating patients' unmet needs in hidradenitis suppurativa: results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project. Journal of The American Academy of Dermatology 82 (2) 10.1016/j.jaad.2019.06.1301

Frew, J.W., Navrazhina, K., Byrd, A.S., Garg, A., Ingram, J.R., Kirby, J.S., Lowes, M.A., Naik, H., Piguet, V. and Prens, E.P. 2019. Defining lesional, perilesional and unaffected skin in hidradenitis suppurativa: proposed recommendations for clinical trials and translational research studies. British Journal of Dermatology 181 (6) 10.1111/bjd.18309

Ingram, J.R. and Ahluwalia, A. 2019. The pharmacology of itch. British Journal of Dermatology , -. 10.1111/bjd.18525

Wernham, A, Kilgour, J, Ingram, J. R. and Matin, R. N. 2019. A five-year review of quality of reporting of research using clinician surveys in high-ranked dermatology journals. British Journal of Dermatology 181 (4) , pp. 845-847. 10.1111/bjd.17942

Ingram, J.R. 2019. BJD: onwards and upwards. British Journal of Dermatology 181 (1) , pp. 1-2. 10.1111/bjd.18034

Prinsen, Cecilia AC., Spuls, Phyllis I., Kottner, Jan, Thomas, Kim, Apfelbacher, Christian, Chalmers, Joanne, Deckert, Stephanie, Furue, Masutaka, Gerbens, Louise, Kirkham, Jamie, Simpson, Eric, Alam, Murad, Balzer, Katrin, Beeckman, Dimitri, Eleftheriadou, Viktoria, Ezzedine, Khaled, Horbach, Sophie ER., Ingram, John R., Layton, Alison, Weller, Karsten, Wild, Thomas, Wolkerstorfer, Albert, Williams, Hywel and Schmitt, Jochen 2019. Navigating the landscape of core outcome set development in dermatology. Journal of the American Academy of Dermatology 81 (1) , pp. 297-305. 10.1016/j.jaad.2019.03.009

Ingram, J.R., Collier, F., Brown, D., Burton, T., Burton, J., Chin, M.F., Desai, N., Goodacre, T.E.E., Piguet, V., Pink, A.E., Exton, L.S. and Mohd Mustapa, M.F. 2019. British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018. British Journal of Dermatology 180 (5) , pp. 1009-1017. 10.1111/bjd.17537

Ho, B., Heelan, K., Solman, L., Jones, R., Dua, J., Ingram, J. R. and Flohr, C. 2019. A survey of the treatment and management of patients with severe chronic spontaneous urticaria. Clinical and Experimental Dermatology 44 (3) , pp. 353-355. 10.1111/ced.13778

Scrivens, L.J., Jacquet, L. and Ingram, J.R. 2019. BJD Medical Student Editors: reaching out to undergraduates in a rapidly evolving world of digital dermatology publishing. British Journal of Dermatology 180 (2) , pp. 251-252. 10.1111/bjd.17397

Callander, Jenny, Robson, Y., Ingram, John R. and Piguet, Vincent 2018. Treatment of clinically amyopathic dermatomyositis in adults: a systematic review. British Journal of Dermatology 179 (6) , pp. 1248-1255. 10.1111/bjd.14726

Thorlacius, L., Ingram, J. R., Villumsen, B., Esmann, S., Kirby, J. S., Gottlieb, A. B., Merola, J. F., Dellavalle, R., Nielsen, S. M., Christensen, R., Garg, Amit and Jemec, G. B. E. 2018. A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process. British Journal of Dermatology 179 (3) , pp. 642-650. 10.1111/bjd.16672

Garcia-Doval, I., Albrecht, J., Flohr, C., Batchelor, J. and Ingram, J. R. 2018. Optimizing case reports and case series: guidance on how to improve quality. British Journal of Dermatology 178 (6) , pp. 1257-1262. 10.1111/bjd.16467

Wernham, A.G.H., Ingram, John R. and Matin, R.N. 2018. Clinician surveys: time to make better use of this valuable resource for dermatologists. British Journal of Dermatology 178 (6) , pp. 1466-1467. 10.1111/bjd.16444 Item availability restricted.

Ingram, John R 2018. Atopic eczema and cardiovascular disease. BMJ 361 , k2064. 10.1136/bmj.k2064

Ingram, John R., Jenkins-Jones, S., Knipe, D. W., Morgan, C. L. I., Cannings-John, Rebecca and Piguet, Vincent 2018. Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa. British Journal of Dermatology 178 (4) , pp. 917-924. 10.1111/bjd.16101

Thorlacius, L., Garg, A., Ingram, J.R., Villumsen, B., Theut Riis, P., Gottlieb, A.B., Merola, J.F., Dellavalle, R., Ardon, C., Baba, R., Bechara, F.G., Cohen, A.D., Daham, N., Davis, M., Emtestam, L., Fernández-Peñas, P., Filippelli, M., Gibbons, A., Grant, T., Guilbault, S., Gulliver, S., Harris, C, Harvent, C., Houston, K., Kirby, J.S., Matusiak, L., Mehdizadeh, A., Mojica, T., Okun, M., Orgill, D., Pallack, L., Parks-Miller, A., Prens, E.P., Randell, S., Rogers, C., Rosen, C.F., Choon, S.E., van der Zee, H.H., Christensen, R. and Jemec, G.B.E. 2018. Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II. British Journal of Dermatology 178 (3) , pp. 715-721. 10.1111/bjd.16093

George, S.M.C. and Ingram, John 2018. BJD support for dermatology journal clubs: nurturing Sir William Osler's legacy. British Journal of Dermatology 178 (2) , pp. 313-314. 10.1111/bjd.16164

Ingram, John, Coulman, Elinor, Gregory, Clive, Thomas-Jones, Emma, Francis, Nicholas, Harding, Keith, Hood, Kerenza, Piguet, Vincent, Pickles, Timothy and Cannings-John, Rebecca 2018. Levels of wound calprotectin and other inflammatory biomarkers aid in deciding which patients with a diabetic foot ulcer need antibiotic therapy (INDUCE study). Diabetic Medicine 35 (2) , pp. 255-261. 10.1111/dme.13431

Sbidian, Emilie, Chaimani, Anna, Garcia-Doval, Ignacio, Do, Giao, Hua, Camille, Mazaud, Canelle, Droitcourt, Catherine, Hughes, Carolyn, Ingram, John R., Naldi, Luigi, Chosidow, Olivier and Le Cleach, Laurence 2017. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews (12) , CD011535. 10.1002/14651858.CD011535.pub2

Zouboulis, C. C., Tzellos, T., Kyrgidis, A., Jemec, G. B. E., Bechara, F. G., Giamarellos-Bourboulis, E. J., Ingram, John R., Kanni, T., Karagiannidis, I., Martorell, A., Matusiak, L., Pinter, A., Prens, E. P., Presser, D., Schneider-Burrus, S., von Stebut, E., Szepietowski, J. C., van der Zee, H. H., Wilden, S. M. and Sabat, R. 2017. Development and validation of IHS4, a novel dynamic scoring system to assess hidradenitis suppurativa/acne inversa severity. British Journal of Dermatology 177 (5) , pp. 1401-1409. 10.1111/bjd.15748 Item availability restricted.

Garcia-Doval, I., van Zuuren, E.J., Bath-Hextall, F. and Ingram, John R. 2017. Systematic reviews: let's keep them trustworthy. British Journal of Dermatology 177 (4) , pp. 888-889. 10.1111/bjd.15826

Callander, J., Anstey, A.V., Ingram, John R., Limpens, J., Flohr, C. and Spuls, P.I. 2017. How to write a Critically Appraised Topic: evidence to underpin routine clinical practice. British Journal of Dermatology 177 (4) , pp. 1007-1013. 10.1111/bjd.15873

Atwan, Ausama, Piguet, Vincent, Finlay, Andrew Y., Francis, Nicholas A. and Ingram, John R. 2017. Dermatology life quality index (DLQI) as a psoriasis referral triage tool. British Journal of Dermatology 177 (4) , e136-e137. 10.1111/bjd.15446

Tang, Hiu Kwan Carolyn, Lee, Doreen Yin Hui, Thompson, Ian, Ingram, John R., Stone, Natalie and Patel, Girish K. 2017. Delayed and localized pemphigus vulgaris after breast cancer radiotherapy. The Breast Journal 23 (6) , pp. 747-749. 10.1111/tbj.12910

Ingram, John R. 2017. Interventions for hidradenitis suppurativa. JAMA Dermatology 153 (5) , pp. 458-459. 10.1001/jamadermatol.2017.0432

Williams, Hywel C., Wojnarowska, Fenella, Kirtschig, Gudula, Mason, James, Godec, Thomas R., Schmidt, Enno, Chalmers, Joanne R., Childs, Margaret, Walton, Shernaz, Harman, Karen, Chapman, Anna, Whitham, Diane, Nunn, Andrew J., Adams, J, Akhras, V, Anstey, A, Barnard, C, Bell, H, Blackford, S, Bröcker, E, Carmichael, A, Coelho, R R, Craig, F, Davies, K, Ellis, R, English, J, Gläser, R, Groves, R, Günthert, C, Hampton, P J, Hepburn, N, Hügel, R, Hussain, K, Ingram, John R., Layton, A M, Levell, N J, Lewis, V, Malhomme, H, Omerod, A, Patel, G, Rallan, R, Ravenscroft, J, Santander, H, Steinbrink, K, Sticherling, M, Thomas, C, Vatve, M, van Beek, N, Venning, V, Veysey, E, Wachsmuth, R, Wahie, S, Walker, B, Walsh, M, Wee, J, Westmoreland, M, Wong, G, Ferguson, Adam, Verpetinske, Indre, Duarte-Williamson, Emilia, Antony, Fiona, Bower, Chris, Gawkrodger, David, Taghipour, Kathy, Dunnill, M G S, Waters, Alex, Bottomley, Walter, Wright, Andrew, Sterling, Jane, Azam, Adzura, Gibbs, Sam, Luger, Thomas, Salvary, Ingrid, Lovell, Chris, Ilchyshyn, Andrew, Gibbon, Karem, Nik, Marinella, Charles-Holmes, Robert and Lavery, A. Lloyd 2017. Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial. Lancet 389 (10079) , pp. 1630-1638. 10.1016/S0140-6736(17)30560-3

Ingram, John R. and Burton, T. 2017. NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics? British Journal of Dermatology 176 (2) , pp. 281-282. 10.1111/bjd.15255

Thorlacius, Linnea, Ingram, John R., Garg, Amit, Villumsen, Bente, Esmann, Solveig, Kirby, Joslyn S., Gottlieb, Alice B., Merola, Joseph F., Dellavalle, Robert, Christensen, Robin and Jemec, Gregor B. E. 2017. Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes. BMJ Open 7 (2) , e014733. 10.1136/bmjopen-2016-014733

Tappenden, Paul, Carroll, Christopher, Stevens, John W., Rawdin, Andrew, Grimm, Sabine, Clowes, Mark, Kaltenthaler, Eva, Ingram, John R., Collier, Fiona and Ghazavi, Mohammad 2017. Adalimumab for treating moderate-to-severe hidradenitis suppurativa: an evidence review group perspective of a NICE single technology appraisal. PharmacoEconomics 35 (8) , pp. 805-815. 10.1007/s40273-017-0488-2

Ingram, John R. and Anstey, A. 2017. The evolution of clinical guidelines for dermatologists: GRADE, AGREE and occasionally consensus by experts. British Journal of Dermatology 176 (1) , pp. 3-4. 10.1111/bjd.15178

Mukkanna, Krishna Sumanth, Stone, Natalie M and Ingram, John R. 2017. Para-phenylenediamine allergy: current perspectives on diagnosis and management. Journal of Asthma and Allergy 10 , pp. 9-15. 10.2147/JAA.S90265

Thomas, Kim S., Ormerod, Anthony D., Craig, Fiona E., Greenlaw, Nicola, Norrie, John, Mitchell, Eleanor, Mason, James M., Johnston, Graham A., Wahie, Shyamal, Williams, Hywel C., Barnes, Julie, Barnes, Brian, Craig, Fiona, Foster, Katharine, Greenlaw, Nicola, Harrison, Ellie, Kucyj, Sally, Maplethorpe, Alan, Mason, James, Mitchell, Eleanor, Norrie, John, Shafayat, Aisha, Simpkins, Daniel, Whitham, Diane, Lawson, Linda, Anstey, Alex, Watkins, Catherine, Mitchell, Sarah, Goodwin, Richard, Benge, Cilla, Skibinska, Gosia, Ariffin, N., Armitt, Janice, Mguni, Nhlanhla, Masuku, Maxwell, Goodsell, Kerry, Johnson, Linda, Ingram, John R., Patel, Girish, Chowdhury, Mabs, Motley, Richard, Thomas, Anne, Long, Colin, Morris, Anew, Piguet, Vincent, Kalavala, Manju, Katugampla, Ru, Blasdale, Catherine, Lateo, Stephanie, Rajan, Neil, Thomson, Anne, Natarajan, Sivakumar, Wahie, Shyamal, Sripathy, Therese, Vatve, Maneesha, Bajaj, Vrinda, Thomson, Anne, Freeman, Keith, Carr, Mary, Ferguson, Adam, Riches, Katherine, Baron, Susannah, Fuller, Claire, Potter, Anthea, Brockway, Laura, Cooper, Ashley, Thompson, Susan, Duarte-Williamson, Emilia, Smith, Catherine, Minifie, Gemma, Hare, Naomi, Thornberry, Kate, Gupta, Shika, Langan, Sinead, Layton, Alison, Wray, Angela, Walker, Benjamin, Law, Gayle, Marshall, Elizabeth, Walton, Shernaz, Ashton, Katherine, Oswald, Angela, Graham, Deborah, Jones, Peter, Smith, Vanessa, Shipley, Debbie, Duggan, Claire, Jones, Sarah, Thomas, Carol, Rolls, Sally-Ann, Veysey, Emma, Meggitt, Simon, Levell, Nick, Lee, Kevin, Rakvit, Pariyawan, Millington, George, Banks-Dunnell, Karen, Chetty, Natasha, Grattan, Clive, Shah, Syed, Butcher, Donna, Nik, Marinela, Gilbanks, Kathleen, Cox, Neil, English, John, Murphy, Ruth, Perkins, William, Littlewood, Sheelagh, Bong, Jan, Malik, Moona, Batchelor, Jonathan, Wootton, Catriona, Davies-Jones, Sue, Llewellyn, Joanne, Cheng, Suzanne, Sharma, Maulina, Angus, Janet, Varma, Sandeep, Cohen, Stuart, English, John, Murphy, Ruth, Perkins, William, Williams, Hywel, Littlewood, Sheelagh, Bong, Jan, Malik, Moona, Batchelor, Jonathan, Wootton, Catriona, Davies-Jones, Sue, Llewellyn, Joanne, Cheng, Suzanne, Sharma, Maulina, Angus, Janet, Varma, Sandeep, Cohen, Stuart, Ogg, Graham, Burge, Susan, Venning, Vanessa, Cooper, Susan, McPherson, Tess, Matter, Lisa, Bower, Christopher, James, Robert, Velangi, Shireen, Szczecinska, Weronika, Shumba, Tinomuda, Ravenscroft, Jane, English, John, Bong, Jan, Yaakub, Azaharry, Trinh, Hong, Chapman, Anna, Miller, Natalie, Estfan, Yana, Reeves, Gwendoline, Wachsmuth, Rachel, Lewis, Victoria, Bell, Hazel, Azurdia, Richard, Walsh, Maeve, Angit, Caroline, Ngan, Kok, Young, Anea, Murgaza, Julie, Taylor, Paula, Hunter, Hamish, Martin-Clavijo, Agustin, Raghavenan, Renuga, Evriviades, Lucy, Lewis, Helen, Dunnill, Giles, Bray, Adam, De Berker, David, Johnston, Graham, McKenna, John, Shelley, Catherine, Ghazavi, Mohammad, Hill, Alison, Kirkup, Maggie, Saunders, Glenn, Lloyd-Jones, Hugh, Simmons, Dawn and Cotterill, Donna 2016. Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: a prospective cohort study. Journal of the American Academy of Dermatology 75 (5) , pp. 940-949. 10.1016/j.jaad.2016.06.016

Daxhelet, M., Suppa, M., Benhadou, F., Djamei, V., Tzellos, T., Ingvarsson, G., Boer, J., Martorell, A., Ingram, John R., Desai, N., Nassif, A., Revuz, J., Hotz, C., Bettoli, V., Deckers, I.E., Jemec, G.B., Prens, E., Zouboulis, C.C. and del Marmol, V. 2016. Establishment of a European Registry for hidradenitis suppurativa/acne inversa by using an open source software. Journal of the European Academy of Dermatology and Venereology 30 (8) , pp. 1424-1426. 10.1111/jdv.13267

Ingram, John R., Woo, P. N., Chua, S. L., Ormerod, A. D., Desai, N., Kai, A. C., Hood, K., Burton, T., Kerdel, F., Garner, S. E. and Piguet, Vincent 2016. Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality. British Journal of Dermatology 174 (5) , pp. 970-978. 10.1111/bjd.14418

Atwan, A., Ingram, John R., Abbott, Rachel, Kelson, Mark James, Pickles, Timothy E., Bauer, A. and Piguet, Vincent 2016. Oral fumaric acid esters for psoriasis: abridged Cochrane systematic review including GRADE assessments. British Journal of Dermatology 175 (5) , pp. 873-881. 10.1111/bjd.14676

Ingram, John R., Hadjieconomou, Sofia and Piguet, Vincent 2016. Development of core outcome sets in hidradenitis suppurativa:a systematic review of outcome measure instruments to inform the process. British Journal of Dermatology 175 (2) , pp. 263-272. 10.1111/bjd.14475

Ingram, John R. 2016. Hidradenitis suppurativa: an update. Clinical Medicine 16 (1) , pp. 70-73. 10.7861/clinmedicine.16-1-70

Ingram, John R, 2016. The genetics of Hidradenitis Suppurativa. Dermatologic Clinics 34 (1) , pp. 23-28. 10.1016/j.det.2015.07.002

Ingram, John R. and Paul, C. 2015. Academic mentorship in dermatology. British Journal of Dermatology 173 (5) , pp. 1113-1114. 10.1111/bjd.14197

Ingram, John R. and McPhee, M. 2015. Management of hidradenitis suppurativa: a UK survey of current practice. British Journal of Dermatology 173 (4) , pp. 1070-1072. 10.1111/bjd.13866

Ingram, John R., Woo, Pick-Ngor, Chua, Ser Ling, Ormerod, Anthony D., Desai, Nemesha, Kai, Anneke C., Hood, Kerenza, Burton, Tara, Kerdel, Francisco, Garner, Sarah and Piguet, Vincent 2015. Interventions for hidradenitis suppurativa. Cochrane Database of Systematic Reviews (10) , CD010081. 10.1002/14651858.CD010081.pub2

Atwan, Ausama, Ingram, John, Abbott, Rachel, Kelson, Mark, Pickles, Timothy, Bauer, Andrea and Piguet, Vincent 2015. Oral fumaric acid esters for psoriasis. Cochrane Database of Systematic Reviews (8) , CD010497. 10.1002/14651858.CD010497.pub2

George, S.M.C. and Ingram, John R. 2015. Introducing cover image as a new category of publication in the BJD. British Journal of Dermatology 173 (2) , p. 315. 10.1111/bjd.13964

Ormerod, Anthony D., Thomas, Kim S., Craig, Fiona E., Mitchell, Eleanor, Greenlaw, Nicola, Norrie, John, Mason, James M., Walton, Shernaz, Johnston, Graham A., Williams, Hywel C. and Ingram, John R. 2015. Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. BMJ 350 , h2958. 10.1136/bmj.h2958

Chalmers, J. R., Wojnarowska, F., Kirtschig, G., Nunn, A. J., Bratton, D. J., Mason, J., Foster, K. A., Whitham, D., Williams, H. C., Ingram, John R. and BLISTER Study Group, 2015. A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg-1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trial. British Journal of Dermatology 173 (1) , pp. 227-234. 10.1111/bjd.13729

Nankervis, Helen, Devine, Alison, Williams, Hywel C, Ingram, John R., Doney, Elizabeth, Delamere, Finola, Smith, Sherie and Thomas, Kim S 2015. Validation of the global resource of eczema trials (GREAT database). BMC Dermatology 15 (4) 10.1186/s12895-015-0024-z

Ingram, John 2014. Hidradenitis suppurativa outcome measures and treatment goals. British Journal of Dermatology 171 (6) , pp. 1293-1294. 10.1111/bjd.13396

Ingram, John 2014. The quest for excellence (part 2): reviewing a clinical trial for the British Journal of Dermatology. British Journal of Dermatology 171 (6) , pp. 1277-1278. 10.1111/bjd.13445

Warburton, K. L., McPhee, M. J., Savage, L. J., Honan, A. E., Montgomery, R., Ghazavi, M., Torley, D., Shams, K. and Ingram, John R. 2014. Management of morphoea: results of a national survey of UK clinicians. British Journal of Dermatology 171 (5) , pp. 1243-1245. 10.1111/bjd.13062

Ingram, John 2014. The quest for excellence (part 1): becoming a reviewer for the British Journal of Dermatology. British Journal of Dermatology 171 (5) , pp. 921-922. 10.1111/bjd.13404

Ingram, John R., Abbott, R., Ghazavi, M., Alexandroff, A. B., McPhee, M., Burton, T. and Clarke, T. 2014. The Hidradenitis Suppurativa Priority Setting Partnership. British Journal of Dermatology 171 (6) , pp. 1422-1427. 10.1111/bjd.13163

Ingram, John R., Desai, N., Kai, A., Chua, S., Woo, P., Kerdel, F., Burton, T., Ormerod, A. D., Hood, K. and Piguet, V. 2014. A Cochrane Systematic Review of interventions for Hidradenitis Suppurativa. Journal of Investigative Dermatology 134 , S40-S40.

Chin, M. F., Abbott, R., Ingram, John R. and Motley, R. J. 2014. Patient-reported outcome measure of pain experienced during administration of local anaesthesia in cutaneous surgery: a tool for appraisal [Abstract]. British Journal of Dermatology 171 , p. 80.

Ingram, John R., Hughes, T. Meirion and Stone, Natalie M. 2014. Potential danger of hair dyes marketed as free from para-phenylenediamine. International Journal of Dermatology 53 (4) , e257-e258. 10.1111/ijd.12296

Ingram, John R. 2013. Interpreting outcome measures and defining treatment success. British Journal of Dermatology 169 (6) , pp. 1177-1178. 10.1111/bjd.12709

Ponnambath, N., Kalavala, M., Anstey, A. V., Piguet, Vincent and Ingram, John R. 2013. Practical experience of biological treatment of very severe psoriasis: a retrospective case-cohort study of patients with a baseline Psoriasis Area and Severity Index score greater than 20 [Abstract]. British Journal of Dermatology 169 (s1) , p. 41. 10.1111/bjd.12306

Matin, R. N., Batchelor, J. M., Flohr, C., Macbeth, A. E., Smith, E., Layfield, C., Ingram, John R. and Williams, H. C. 2013. The UK Dermatology Clinical Trials Network Trainee Group: developing evidence-based practice and research engagement among dermatology trainees. British Journal of Dermatology 169 , p. 35.

Ingram, John R., Belgi, G., Cook, L. J., Hughes, B. R., Karim, A. and Finlay, Andrew Yule 2013. Segmental cherry angiomas associated with extragenital lichen sclerosus: a report of two cases. Clinical and Experimental Dermatology 38 (4) , pp. 386-389. 10.1111/j.1365-2230.2012.04479.x

Ingram, John R. and Piguet, Vincent 2013. Phenotypic heterogeneity in Hidradenitis Suppurativa (Acne Inversa): classification is an essential step toward personalized therapy. Journal of Investigative Dermatology 133 (6) , pp. 1453-1456. 10.1038/jid.2012.476

Burr, Michael Leslie, Dunstan, Frank David, Hand, Sadiyah, Ingram, John Robert and Jones, K. 2013. The natural history of eczema from birth to adult life: a cohort study. British Journal of Dermatology 168 (6) , pp. 1339-1342. 10.1111/bjd.12216

Ingram, John R., Anderson, Elizabeth J. and Pugsley, Lesley 2013. Difficulty giving feedback on underperformance undermines the educational value of multi-source feedback. Medical Teacher 35 (10) , pp. 838-846. 10.3109/0142159X.2013.804910

Ingram, John R., Wood, M., John, B., Butler, R. and Anstey, A. V. 2013. Absence of pathogenic gamma-secretase mutations in a South Wales cohort of familial and sporadic hidradenitis suppurativa (acne inversa). British Journal of Dermatology 168 (4) , pp. 874-876. 10.1111/bjd.12048

Ingram, John R., Wood, M., John, B., Butler, R. and Anstey, Alexander Vincent 2013. Absence of pathogenic γ-secretase mutations in a South Wales cohort of familial and sporadic hidradenitis suppurativa (acne inversa). British Journal Of Dermatology 168 (4) , pp. 874-876. 10.1111/bjd.12048

Ingram, John R., Anstey, Alexander Vincent and Piguet, Vincent 2012. Combination treatment with a tumour necrosis factor antagonist and an oral retinoid: efficacy in severe acral psoriasis? [Letter]. British Journal Of Dermatology 167 (4) , pp. 949-951. 10.1111/j.1365-2133.2012.10983.x

Ingram, John R., Gasson, Peter, Hughes, T. Meirion and Stone, Natalie M. 2012. A bum deal from wooden toilet seats: reemergence of allergic contact dermatitis. Dermatitis 23 (5) , pp. 244-245.

Enk, Alexander, Ingram, John R. and Piguet, Vincent 2012. Future leaders: mentor investment in young investigators. Journal of Investigative Dermatology 132 (8) , pp. 1943-1944. 10.1038/jid.2012.55

Hodges, Nick, Anstey, Alex and Ingram, John R. 2012. Fumaric acid esters for psoriasis: patient perceptions of an unlicensed medication [Abstract]. Journal of the American Academy of Dermatology 66 (4) , AB193-AB193. 10.1016/j.jaad.2011.11.809

Craig, Fiona F., Thomas, Kim S., Mitchell, Eleanor J., Williams, Hywel C., Norrie, John, Mason, James M, Ormerod, Anthony D., Ingram, John R. and UK Dermatology Clinical Trials Network’s STOP GAP Trial Team, 2012. UK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial. Trials 13 (1) , p. 51. 10.1186/1745-6215-13-51

Ingram, John R., Wood, Michelle, John, Bethan, Butler, Rachel and Anstey, Alexander Vincent 2011. Absence of pathogenic gamma-secretase mutations in familial and sporadic acne inversa in a European population [Abstract]. Journal of Investigative Dermatology 131 (Supp 2) , S68-S68. 10.1038/jid.2011.214

Ingram, John R. 2011. The aetiology of acne inversa: an evolving story. British Journal of Dermatology 165 (2) , pp. 231-232. 10.1111/j.1365-2133.2011.10459.x

Ali, Faraz, Ingram, John R., Whatley, Sharon, Badminton, Michael Norman and Anstey, Alexander Vincent 2011. X-linked dominant protoporphyria due to a novel mutation in ALAS2: a case report [Abstract]. British Journal of Dermatology 164 (5) , p. 1167. 10.1111/j.1365-2133.2011.10357.x

Ingram, John R., Cole, D. S., Czajkowski, M., Anstey, Alexander Vincent and Badminton, Michael Norman 2011. An unusual complication of jaundice [Abstract]. British Journal of Dermatology 164 (5) , p. 1168. 10.1111/j.1365-2133.2011.10357.x

Ingram, John R., Grindlay, Douglas J. C. and Williams, Hywel C. 2010. Problems in the reporting of acne clinical trials: a spot check from the 2009 Annual Evidence Update on Acne Vulgaris. Trials 11 , 77. 10.1186%2F1745-6215-11-77

Ingram, John R., Grindlay, D. J. C. and Williams, H. C. 2010. Management of "acne vulgaris": an evidence-based update. Clinical and Experimental Dermatology 35 (4) , pp. 351-354. 10.1111/j.1365-2230.2009.03683.x

Paulden, M., Rodgers, M., Griffin, S., Slack, R., Duffy, S., Ingram, John R., Woolacott, N. and Sculpher, M. 2010. Alitretinoin for the treatment of severe chronic hand eczema. Health Technology Assessment 14 , pp. 39-46. 10.3310/hta14Suppl1/06

Rodgers, Mark, Griffin, Susan, Paulden, Mike, Slack, Russell, Duffy, Steven, Ingram, John R., Woolacott, Nerys and Sculpher, Mark 2010. Alitretinoin for severe chronic hand eczema: a NICE single technology appraisal. Pharmacoeconomics 28 (5) , pp. 351-362. 10.2165/11532160-000000000-00000.

Batchelor, Jonathan M., Ingram, John R. and Williams, Hywel 2009. Adalimumab vs Methotrexate for the treatment of chronic plaque psoriasis. Archives of Dermatology 145 (6) , pp. 704-706. 10.1001/archdermatol.2009.104

Ingram, John R. 2009. Nicotine: does it have a role in the treatment of skin disease? Postgraduate Medical Journal 85 (1002) , pp. 196-201. 10.1136/pgmj.2008.073577.

Ingram, John R., Batchelor, Jonathan M. and Williams, Hywel C. 2009. Alitretinoin as a potential advance in the management of severe chronic hand eczema. Archives of Dermatology 145 (3) , pp. 314-315. 10.1001/archdermatol.2008.608.

Ingram, John R., Griffiths, A. P. and Roberts, D. L. 2009. All patients with sebaceous gland neoplasms should be screened for Muir-Torre syndrome. Clinical and Experimental Dermatology 34 (2) , pp. 264-266. 10.1111/j.1365-2230.2008.02830.x

Ingram, John R., Martin, Julie A. and Finlay, Andrew Y. 2009. Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis. American Journal of Clinical Dermatology 10 (4) , pp. 229-237. 10.2165/00128071-200910040-00003.

Ingram, John R., Hughes, Meirion and Stone, Natalie M. 2008. Occupational allergic contact dermatitis to polyfunctional aziridine crosslinker in a 'tufter'. Contact Dermatitis 58 (3) , 172-U7. 10.1111/j.1600-0536.2007.01216.x

Ingram, John R., Rhodes, J., Evans, B. K. and Thomas, G. A. O. 2008. Nicotine enemas for active Crohn's colitis: an open pilot study. Gastroenterology Research and Practice 2008 , 237185.

Ingram, John R., Rhodes, J., Evans, B. K. and Thomas, G. A. O. 2005. Preliminary observations of oral nicotine therapy for inflammatory bowel disease: An open-label phase I-II study of tolerance. Inflammatory Bowel Diseases 11 (12) , pp. 1092-1096.

Ingram, John R., Rhodes, J., Collins, P. W., Williams, G. T., Newcombe, R. G. and Thomas, G. A. O. 2005. Plasma fibrinogen in ulcerative colitis: The effect of disease activity and nicotine therapy in a randomised controlled trial. Digestive and Liver Disease 37 (11) , pp. 832-837. 10.1016/j.dld.2005.05.010

Thomas, G. A. O., Rhodes, J. and Ingram, John R. 2005. Mechanisms of disease: nicotine - a review of its actions in the context of gastrointestinal disease. Nature Clinical Practice Gastroenterology & Hepatology 2 (11) , pp. 536-544. 10.1038/ncpgasthep0316

Ingram, John R., Thomas, G. A. O., Rhodes, J., Green, J. T., Hawkes, N. D., Swift, J. Ll, Srivastava, E. D., Evans, B. K., Williams, G. T., Newcombe, R. G., Courtney, E. and Pillai, S. 2005. A randomized trial of nicotine enemas for active ulcerative colitis. Clinical Gastroenterology and Hepatology 3 (11) , pp. 1107-1114. 10.1016/S1542-3565(05)00849-9